Page 72 - ESHRE2019
P. 72
Applying economics to improve access to ART treatment
Mark Connolly Ph.D.
University of Groningen, Netherlands, guest lecturer
M.Connolly@rug.nl
Global Market Access Solutions, Switzerland, United States
mark@gmasoln.com
13:30 - 14:00
Disclosures
• Previously received funding from pharmaceutical companies for health economics research. Companies include Vifor, Gilead, Amgen, Alnylam, Abbott, GSK.
• A portion of work described here was funded by the WHO in Geneva in 2018.
70
67
